Ogura_Kawai 2012
Alveolar Soft Part Sarcoma: A Single-Center 26-Patient Case
Series and Review of the Literature
Goldberg_Dranoff 2015
Biologic Activity of Autologous, Granulocyte-Macrophage
Colony Stimulating Factor Secreting Alveolar Soft Parts
Sarcoma and Clear Cell Sarcoma Vaccines
Kuriyama_Morimoto 2001
Alveolar Soft Part Sarcoma With Lung
Metastases. Response to Interferon Alpha-2a?
Covell_Vistica 2012
Bioinformatic Analysis of Patient-Derived ASPS Gene
Expressions and ASPL-TFE3 Fusion Transcript Levels
Identify Potential Therapeutic Targets
Hoshino_Endo 2009
Molecular analyses of cell origin and detection of circulating tumor cells
in the peripheral blood in alveolar soft part sarcoma
Azizi_Slav 2006
Vascular-endothelial-growth-factor (VEGF) expression and
possible response to angiogenesis inhibitor bevacizumab in
metastatic alveolar soft part sarcoma
Ishiguro_Kaneko 2004
Established and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript
Soiffer_Dranoff 1998
Vaccination with irradiated autologous melanoma cells engineered
to secrete human granulocyte–macrophage colony-stimulating
factor generates potent antitumor immunity in patients with
metastatic melanoma
Dranoff 2003
GM-CSF-secreting melanoma vaccines
Roozendaal_Kroon 2003
Alveolar soft-part sarcoma responding to interferon alpha-2b